M
Marinus Pharma
Profile managed by Bizz IdMarinus Pharmaceuticals / ZTALMY
Estados Unidos
51-200 employees
Description
Pharmaceutical company headquartered in Radnor, Pennsylvania, dedicated to developing innovative therapeutics for seizure disorders. Its product ZTALMY® (ganaxolone) was FDA-approved in March 2022 for CDKL5 deficiency disorder. Acquired by Immedica in February 2025.